PAKOLA STEVE 4
4 · REGENXBIO Inc. · Filed Jan 6, 2026
Insider Transaction Report
Form 4
REGENXBIO Inc.RGNX
PAKOLA STEVE
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2026-01-02$14.40/sh−18,247$262,757→ 192,470 total
Footnotes (1)
- [F1]Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 3, 2022, January 3, 2023, January 2, 2024 and January 2, 2025. The number of shares withheld was determined on January 2, 2026 based on the closing price of the issuer's common stock on December 31, 2025.